ArcticZymes is named Thermo Fischer Scientific “Biological Supplier of the Year”
Tromsø, 16 October 2014: ArcticZymes, a subsidiary of Biotec Pharmacon, announced today that Thermo Fischer Scientific, world leader in serving Life Science, has awarded ArcticZymes with “Biological Supplier of the Year”.
ArcticZymes was acknowledged for their engagement in multiple sales through regional, national and international office’s, Just-in-time inventory, rapid response to non-forecasted demand and a year-on-year downward cost to Thermo Fischer.
“ArcticZymes has worked with Thermo Fischer for years through several of their entities. This award is a great recognition of ArcticZymes’ outstanding services and ability to adopt into new and demanding customer expectations. With this award we believe we can expand our relation to this important customer even further”, stated Svein Lien, CEO of Biotec Pharmacon and ArcticZymes.
ArcticZymes enzymes are included in numerous PCR kits for use in molecular biology and molecular diagnostics. Use of ArcticZymes heat labile and cold adapted enzymes has allowed for simplified practices, and has moved boundaries within diagnostics.
For further information, please contact:
CEO Svein W. F. Lien, +47 922 89 323.
About Biotec Pharmacon ASA:
Biotec Pharmacon ASA is the parent company of Biotec BetaGlucans AS and ArcticZymes AS. Biotec BetaGlucans develops and manufactures novel immunomodulating products, and has recently obtained CE-mark for Woulgan® Biogel containing its proprietary substance SBG®. Woulgan® Biogel is a primary dressing for one-time use on skin wounds, including diabetic ulcers, bedsores, leg ulcers, transplantation wounds, post-surgery wounds, trauma wounds, first- and second-degree burns, abrasions, and cuts.
ArcticZymes develops, produces and sells enzymes of marine origin used in molecular DNA technologies and diagnostics, growth markets where rapid technological developments are creating a strong demand for new and improved enzymes.